CardioDx targets up to $86.25M from IPO

10/13/2013 | American City Business Journals

Palo Alto, Calif.-based CardioDx has filed for an initial public offering, with the goal of securing as much as $86.25 million. The company, which specializes in cardiovascular diagnostic tests, will use the proceeds from the IPO to support new clinical research and development efforts. The company also said it aims to relocate to Redwood City in June.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ